Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NVO
NVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NVO News
Surging Demand for GLP-1 Drugs Benefits Medical Device Companies
14h ago
Fool
Novo Nordisk Faces Challenges but Optimistic Outlook Ahead
15h ago
Fool
U.S. Healthcare Spending Reaches $5.7 Trillion Amid Growth Trends
17h ago
Fool
Eli Lilly and Intuitive Surgical's Growth Potential
17h ago
NASDAQ.COM
Conexeu Completes CXU Preclinical Phase, Targeting Medical Aesthetics Market
22h ago
Newsfilter
Vivani Medical Partners with Novo Nordisk for Semaglutide Implant Evaluation
22h ago
NASDAQ.COM
Conexeu Completes CXU Preclinical Program for Medical Aesthetics Market Entry
22h ago
PRnewswire
Vivani Medical Partners with Novo Nordisk to Evaluate NanoPortal Implant for Semaglutide
23h ago
seekingalpha
Viking Therapeutics Clinical Trial Outlook Analysis
2d ago
Fool
Viking's VK2735 Shows Significant Weight Loss Potential
2d ago
NASDAQ.COM
Eli Lilly's Dominance in Weight Loss Drug Market
2d ago
Fool
Viking Therapeutics Faces Intense Competition in Obesity Drug Market
3d ago
Fool
Viking Therapeutics Faces Market Challenges Ahead of VK2735 Launch
3d ago
NASDAQ.COM
Market Outlook for Viking Therapeutics by 2030
3d ago
Yahoo Finance
Viking Therapeutics' Prospects in the Weight Loss Drug Market
4d ago
Fool
Johnson & Johnson Avoids $100 Billion Weight Loss Market
4d ago
Yahoo Finance
Show More News
